Home›Stock Screener›Transchem

Transchem Share Price Today | Stock Price & Transchem Share Screener

TRANSCHEM Pharmaceuticals
Live Share Price BSE
₹411.30
▼ -3.85 (-0.93%)
2026-10-05 00:00:00

As of October 5, 2026, the live Transchem share price (BSE: TRANSCHEM) is ₹411.30, down 0.93% from the previous close, with shares trading between ₹404.00 and ₹420.50 in today's trading session, and a 52-week range of ₹60.00–₹416.50. Check Transchem yearly highs lows for the annual price range and momentum. Use the Transchem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Transchem opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹13 and net income of ₹7, with EBITDA of ₹9.

Transchem Market Cap ₹504.29 Cr.
TRANSCHEM P/E Ratio (TTM) 75.87
Transchem P/B Ratio 6.10
EPS (TTM) ₹3.51
Dividend Yield -
Debt to Equity -
TRANSCHEM 52 Week High ₹416.50
Transchem 52 Week Low ₹60.00
Operating Margin -
Profit Margin 53.85%
TRANSCHEM Revenue (TTM) ₹13.00
EBITDA ₹9.00
Net Income ₹7.00
Total Assets ₹88.00
Total Equity ₹84.00

Transchem Share Price Chart

Track the current stock price of Transchem with an interactive chart. Analyse TRANSCHEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Transchem stock quote in one place.

The quote of ₹411.30 sits between the 52-week low of ₹60.00 and the 52-week high of ₹416.50, and the latest session moved -0.93% from the previous close.

Transchem Company Profile - Fundamental Screener

Screen Transchem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TRANSCHEM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE019B01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE019B01010

Transchem Balance Sheet Screener

Screen TRANSCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹88, up from ₹80 in 2025.

Latest statistics put total assets at ₹88 and shareholder funds at ₹84.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 88 80 76 66 67 63 37 38 37 38
Current Assets 86 78 67 58 58 55 30 28 30 29
Fixed Assets 0 0 0 0 0 0 4 4 5 6

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 84 79 76 66 66 63 37 38 37 38
Share Capital 12 12 12 12 12 12 12 12 12 12
Reserves & Surplus 71 67 63 54 54 51 25 26 25 26

Transchem Income Statement Screener - Profit & Revenue Analysis

Screen Transchem income statement and profit fundamentals. Analyze TRANSCHEM quarterly results. Transchem reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹13 and net profit was ₹7, equal to earnings per unit of ₹5.50.

In that period expenses were ₹4, interest cost ₹0 and tax ₹2. The next period listed, 2026-March, shows revenue of ₹9 and net profit of ₹4.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 13 9 11 8 4 7 27 3 3 2 2 2 2
Expenses 4 4 4 2 2 3 2 1 1 2 1 1 1

Operating Costs and Margins

EBITDA 9 6 7 6 3 4 25 1 2 0 1 1 1
Operating Profit % 0.00% 0.00% -56.00% -423.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 9 6 7 6 3 4 25 1 1 -1 0 0 0
Tax 2 1 2 1 1 1 1 0 1 1 0 0 0
Net Profit 7 4 5 4 1 3 24 0 0 -1 0 0 0
EPS 5.50 3.51 4.27 3.43 1.01 2.34 19.73 0.33 0.25 -0.97 -0.18 0.04 0.10

Transchem Cash Flow Screener - Liquidity Fundamentals

Screen TRANSCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹3, and net cash flow was an outflow of ₹1.

Over the same period, investing activities provided ₹2 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -3 36 -39 1 22 -28 -1 10 -20 1
Investing Activities 2 6 5 -1 1 23 1 6 20 -2

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow -1 42 -34 0 23 -5 0 16 0 -1

Transchem Shareholding Pattern Screener

See Transchem shareholding pattern with promoter, FII, and DII holdings. Check Transchem promoter holding and ownership changes for TRANSCHEM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 56.45%, foreign institutions 0.03%, domestic institutions 0.01% and the public 20.83%, spread across 13,145 shareholders.

The shareholder count was 13,145 in 2026-Mar, compared with 13,048 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 56.45% 56.45% 56.45% 56.45% 56.45% 56.45% 51.68% 51.68%

Institutional Investors

FII Holding 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
DII Holding 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 20.83% 20.94% 24.69% 24.75% 23.38% 21.78% 27.15% 27.22%
Other Holding 22.68% 22.57% 18.83% 18.76% 20.14% 21.73% 21.14% 21.07%
Shareholder Count 13,145 13,048 13,843 13,767 13,680 13,339 13,813 13,681

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Transchem. Transchem dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Transchem.

Transchem Stock Index Membership - Nifty & Sensex

See which indices include Transchem stock. Check TRANSCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Transchem is not part of any tracked indices.
Only major market indices are tracked in our system.

Transchem Market Events Screener - Corporate Actions

Get Transchem corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Transchem stock events that may affect TRANSCHEM share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 5, 2026, with a record date of September 5, 2026.

It is followed by Quarterly Result Announcement dated August 10, 2026 and Quarterly Result Announcement dated May 5, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-05 2026-09-05 Annual General Meeting NA 19.83%
2026-08-10 2026-08-10 Quarterly Result Announcement NA 3.51%
2026-05-05 2026-05-05 Quarterly Result Announcement NA 1.20%
2026-02-07 2026-02-07 Quarterly Result Announcement NA -3.29%
2025-12-20 2025-12-20 Extraordinary General Meeting NA 126.06%
2025-10-16 2025-10-16 Extraordinary General Meeting NA -17.83%
2025-10-16 2025-10-16 Quarterly Result Announcement NA -1.48%
2025-08-23 2025-08-23 Annual General Meeting NA 15.27%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 2.20%
2025-05-20 2025-05-20 Quarterly Result Announcement NA -1.96%
2025-01-28 2025-01-28 Quarterly Result Announcement NA -7.99%
2024-10-15 2024-10-15 Quarterly Result Announcement NA 9.22%
2024-08-24 2024-08-24 Annual General Meeting NA -5.31%

Transchem Competitors Screener - Peer Stocks Comparison

Screen TRANSCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Transchem Company Announcements - News & Reports Screener

Screen TRANSCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated September 27, 2026 and September 7, 2026.

Date Update Actions
2026-10-02 Minutes Of The 49Th Annual General Meeting Of The Company -
2026-09-27 Closure of Trading Window -
2026-09-07 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-05 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-17 Announcement under Regulation 30 (LODR)-Updates on Acquisition -
2026-08-17 Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements -
2026-08-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-10 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-08-10 Amendment To The Code Of Conduct For Prevention Of Insider Trading -
2026-08-10 Un-Audited Financial Results For The Quarter Ended June 30 2026 -
2026-08-10 Board Meeting Outcome for The Meeting Held On August 10 2026 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-08-03 Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended June 30 2026 -
2026-08-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-31 Letter To Members Pursuant To Regulation 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-07-31 Reg. 34 (1) Annual Report. -
2026-07-31 Notice Of The 49Th Annual General Meeting Of The Members Of The Company And Annual Report For The Financial Year 2025-26 -
2026-07-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-06-05 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-06-05 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹411.30, within a 52-week range of ₹60.00 to ₹416.50. The P/E ratio is 75.87 and the P/B ratio is 6.10, with earnings per unit of ₹3.51. Market capitalisation stands at ₹504.29 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.